We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




DNA Repair Mechanism Maintains Genetic Stability

By Biotechdaily staff writers
Posted on 08 Nov 2002
Researchers working with Escherichia coli have observed a mechanism for DNA repair that functions to correct errors remaining after primary repair and helps to maintain the genetic stability of the organism. More...
This finding was reported in the October 2002 issue of Molecular Cell.

When primary DNA repair mechanisms fail, cell death usually prevents the incorporation of mutations into the genome. However, when gross DNA repair is successful, some areas of the genome still contain damaged areas that may lead to the propagation of mutations (usually unfavorable). The recombinational repair (RR) mechanism employed by E coli to repair this type of damaged DNA was found by researchers at the Weizmann Institute of Science (Rehovot, Israel) to operate in about 85% of the incidences of DNA damage. The alternate translesion replication (TLR) mechanism functions about 15% of the time. TLR does not completely remove all damage to the genome, as opposed to RR, which corrects all DNA damage. Thus, E coli has evolved a way to correct remaining damaged areas in a way that eliminates mutations and ensures genetic stability.

The repair mechanisms that were studied in E coli have been well preserved throughout evolution, which suggests that variants of these mechanisms exist and operate in more developed organisms, including humans. The findings reported in the current study may help to advance gene therapy of human diseases as well as to suggest ways to circumvent the rapid mutation rate of bacteria that leads to drug resistance.




Related Links:
Weizmann Institute of Science

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Urine Analyzer
respons® UDS100
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.